share_log

Eve & Co Announces Shares for Debt Transaction

Eve & Co Announces Shares for Debt Transaction

Eve&Co宣佈股票進行債務交易
GlobeNewswire ·  2022/01/31 08:36

STRATHROY, Ontario, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Eve & Co Incorporated ("Eve & Co" or the "Company") (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce it has entered into debt settlement agreements (the "Debt Settlement Agreements") with certain directors, officers, employees, and debentureholders (the "Parties") whereby it has agreed to settle an aggregate of $657,000 in payables (the "Payables") owed to the Parties related to expenses, loans and services rendered to the Company up to January 2022 in exchange for an aggregate of 5,189,606 common shares in the capital of the Company (the "Settlement Shares"). The Company is proposing to issue the Settlement Shares to settle the Payables in order to preserve cash for general working capital purposes.

安大略省斯特拉特羅伊,2022年1月31日(環球社)--伊夫公司(Eve&Co Inc.)Eve&Co“或”公司“)(多倫多證券交易所-V:EVE;OTCQX:EEVVF)很高興地宣佈,它已達成債務解決協議(”債務清償協議)與某些董事、高級管理人員、員工和債券持有人(各方“)據此,同意結清總計657,000美元的應付賬款(”應付款)欠各方與截至2022年1月向本公司提供的費用、貸款和服務有關的費用、貸款和服務,以換取本公司股本中總計5,189,606股普通股(結算股份“)。本公司建議發行結算股份以結清應付款項,以保存現金作一般營運資金用途。

Pursuant to the terms of the Debt Settlement Agreements, the Company has agreed to issue an aggregate of 908,677 Settlement Shares at a deemed issuance price of $0.12 per Settlement Share in full and final satisfaction of $109,041 of certain trade payables, directors' fees, and salaries and an aggregate of 4,280,929 Settlement Shares at a deemed issuance price of $0.128 per Settlement Share in full and final satisfaction of $547,959 owed to the holders of the Company's outstanding 10% unsecured convertible debentures that were issued on December 11, 2020.

根據債務和解協議的條款,本公司已同意發行合共908,677股結算股份,當作發行價為每股結算股份0.12美元,以全數及最終清償109,041美元的若干貿易應付款項、董事酬金及薪金,以及合共4,280,929股結算股份,以每股結算股份0.128美元的當作發行價全數及最終清償欠本公司於2020年12月11日發行的未償還10%無擔保可轉換債券持有人的547,959美元

Insiders of the Company (the "Insiders") are expected to receive 1,916,667 Settlement Shares in settlement of $242,500 of debt. Pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"), the settlement of the Payables will constitute a "related party transaction" as the Insiders are considered to be related parties to the Company. The Company will rely on exemptions from the formal valuation and minority approval requirements of MI 61-101 (pursuant to subsections 5.5(a) and 5.7(a)) as the fair market value of the securities to be distributed to, and the consideration received from, the Insiders will not exceed 25% of the Company's market capitalization. The settlement of the Payables has been approved by all of the independent directors of the Company. All securities issued pursuant to the Debt Settlement Agreements will be subject to statutory and TSX Venture Exchange ("TSXV") hold periods until the date that is four months and one day from the date of issuance.

本公司內部人士(“內部人士“)預計將獲得1,916,667股結算股份,以清償242,500美元的債務。根據多邊文書61-101-特殊交易中少數股權持有人的保護("米其林61-101“),應付款項的結算將構成”關聯方交易“,因為內部人士被視為本公司的關聯方。本公司將依據豁免MI 61-101(根據第5.5(A)和5.7(A)款)的正式估值和少數股東批准的要求,作為將分配給內部人士的證券的公平市值,並從內部人士收取不超過本公司市值的25%的對價。應付款項的結算已獲本公司全體獨立董事批准。根據債務清償協議發行的所有證券將受法定和多倫多證券交易所(TSX)風險交易所(“TSXV“)持有期限至發行之日起四個月零一天為止。

Settlement of the Payables and issuance of the Settlement Shares is subject to the acceptance of the TSXV. There is no guarantee that such conditions precedent will be satisfied or that any of the transactions will be completed as described herein or at all.

應付款項的結算及結算股份的發行須經天津市證券及期貨事務監察委員會接納。不能保證這些先例會得到滿足,也不能保證任何交易都會如本文所述那樣完成,或者根本不能保證。

ABOUT EVE & CO

關於Eve&CO

Eve & Co, through its wholly-owned subsidiary Natural Medco Ltd. ("NMC"), holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received its European Union certificate of Good Manufacturing Practice. NMC was Canada's first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario. 

Eve&Co通過其全資子公司Natural Medco Ltd.(“NMC“),根據大麻法案加拿大負責生產和銷售各種大麻產品,包括幹大麻、大麻植物和大麻油提取,並已獲得歐洲聯盟良好製造規範證書。NMC是加拿大第一家由女性創立的有執照的醫用大麻生產商,並於2016年從加拿大衞生部獲得種植許可證。Eve&Co由一個農業專家團隊領導,在安大略省斯特拉特里擁有100萬平方英尺的温室許可。

The Company's website can be visited at .

該公司的網站可通過以下網址訪問:

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

TSXV及其監管服務提供商(該術語在TSXV的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur, and include, but are not limited to, the negative of these words or other variations on these words or comparable terminology. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Forward-looking statements contained in this release include statements with respect to the completion of the debt settlement contemplated in the Debt Settlement Agreements and the ability of the Company to attain the TSXV approval required for the issuance of the Settlement Shares, amongst other matters. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's management's discussion and analysis dated April 30, 2021 (the "MD&A") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at . The Company cautions that the list of risks, uncertainties and other factors described in the MD&A is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

本新聞稿包括含有適用證券法定義的某些“前瞻性信息”的陳述(“前瞻性陳述”)。前瞻性表述經常使用諸如“計劃”、“繼續”、“預期”、“項目”、“打算”、“相信”、“預期”、“估計”、“可能”、“將”、“潛在”、“建議”等類似詞語,或某些事件或條件“可能”或“將”發生的表述,包括但不限於這些詞語的負面影響或這些詞語或類似術語的其他變體。儘管公司認為這些前瞻性陳述中表達的預期是基於合理的假設,但這些陳述並不是對未來業績的保證,涉及難以控制或預測的風險和不確定因素。因此,實際結果和結果可能與這些前瞻性陳述中表達的大不相同,讀者不應過分依賴這些陳述。本新聞稿中包含的前瞻性陳述包括有關債務清償協議中預期的債務清償完成的陳述,以及本公司獲得發行結算股所需的多倫多證券交易所(TSXV)批准的能力以及其他事項的陳述。前瞻性表述受各種風險、不確定因素和其他因素的影響,管理層認為這些因素在當時的情況下是相關和合理的,可能會導致實際事件、結果、活動水平、業績、前景、機會或成就與前瞻性表述中預測的結果大不相同,包括總體商業和經濟狀況、法律法規的變化、產品需求、所需商品的價格變化、競爭、“新冠肺炎”疫情的影響和應對以及其他風險。, 在公司管理層於2021年4月30日提交給加拿大證券監管機構的討論和分析(“MD&A”)中“風險因素”標題下列出的不確定因素和因素可在公司在SEDAR上的發行人簡介中查閲,網址為。該公司告誡説,MD&A中描述的風險、不確定因素和其他因素並不是詳盡的,其他因素也可能對其結果產生不利影響。請讀者在評估前瞻性陳述時仔細考慮風險、不確定性和假設,並告誡讀者不要過度依賴這些信息。這些前瞻性陳述僅在發表之日發表,公司沒有義務公開更新這些陳述,以反映新的信息或未來事件或情況的發生,除非法律另有要求。

For further information, please contact:

如需更多信息,請聯繫:

Melinda Rombouts
President and Chief Executive Officer Eve & Co Incorporated
Telephone: (855) 628-6337

梅林達·羅伯茨
總裁兼首席執行官Eve&Co Inc.
電話:(855)628-6337

47420341.2

47420341.2


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論